Review of prasugrel for the secondary prevention of atherothrombosis.

@article{Spinler2009ReviewOP,
  title={Review of prasugrel for the secondary prevention of atherothrombosis.},
  author={Sarah A. Spinler and Catherine Rees},
  journal={Journal of managed care pharmacy : JMCP},
  year={2009},
  volume={15 5},
  pages={383-95}
}
BACKGROUND The role of platelets in atherothrombotic disease is well established, and antiplatelet therapy is now recommended for the shortand long-term management of patients with acute coronary syndromes (ACS), with and without percutaneous coronary intervention (PCI). The thienopyridine clopidogrel is accepted as a key component of antiplatelet… CONTINUE READING